Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 2 |
2008 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis.
Bioessays. 2007 Jun;29(6):558-65. doi: 10.1002/bies.20582.
Bioessays. 2007.
PMID: 17508401
Free PMC article.
Review.
The T790M "gatekeeper" mutation in EGFR mediates resistance to low concentrations of an irreversible EGFR inhibitor.
Godin-Heymann N, Ulkus L, Brannigan BW, McDermott U, Lamb J, Maheswaran S, Settleman J, Haber DA.
Godin-Heymann N, et al.
Mol Cancer Ther. 2008 Apr;7(4):874-9. doi: 10.1158/1535-7163.MCT-07-2387.
Mol Cancer Ther. 2008.
PMID: 18413800
Item in Clipboard
Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms.
Bell DW, Brannigan BW, Matsuo K, Finkelstein DM, Sordella R, Settleman J, Mitsudomi T, Haber DA.
Bell DW, et al.
Clin Cancer Res. 2008 Jul 1;14(13):4079-84. doi: 10.1158/1078-0432.CCR-07-5030.
Clin Cancer Res. 2008.
PMID: 18593984
Free PMC article.
Item in Clipboard
Oncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutation.
Godin-Heymann N, Bryant I, Rivera MN, Ulkus L, Bell DW, Riese DJ 2nd, Settleman J, Haber DA.
Godin-Heymann N, et al.
Cancer Res. 2007 Aug 1;67(15):7319-26. doi: 10.1158/0008-5472.CAN-06-4625.
Cancer Res. 2007.
PMID: 17671201
Free PMC article.
Item in Clipboard
Cite
Cite